NeurologyLive® Friday 5 — May 6, 2022

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 6, 2022.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Mind Moments Ep. 63: Moving Migraine Toward Personalized Care

Episode 63 Mind Moments™, a podcast from NeurologyLive®, brings you an exclusive interview with Jessica Ailani, MD, who spoke about some recent data in headache medicine that has provided evidence of the in-clinic experience and how the migraine treatment landscape has shifted almost continuously in the past several years.

2: Peers & Perspectives: Novel Treatment Options for the Management of Narcolepsy

In Episode 11 of this NeurologyLive® Peers & Perspectives series "Improving Diagnosis and Patient Outcomes in Narcolepsy," Margaret Park, MD, and Russell Rosenberg, PhD, DABSM, provide insight on novel FDA-approved treatment options and their impact on the narcolepsy treatment landscape.

3: FDA Action Update, April 2022: Extensions, Approvals, and Designations

Catch up on any of the neurology news headlines you may have missed over the course of the last month, compiled all into one place by the NeurologyLive® team.

4: Peer Exchange: Using Diagnostic Tools to Assess Migraine

In Episode 5 of this NeurologyLive® Peer Exchange™ series, "Improving Diagnosis and Patient Outcomes in Narcolepsy," experts in migraine care, Julio R. Vieira, MD; Jessica Ailani, MD; and Bradley Torphy, MD, review diagnostic tools available for migraine, including patient use of headache diaries.

5: Weighing Approaches on Preventive Use, Medication Overuse in Chronic Migraine: Vincent Martin, MD

The president of the National Headache Foundation discussed whether switching or continuing preventive medications has a benefit in patients who have chronic migraine with medication overuse.

—————————————————